顧みられない熱帯病診断市場レポート：2030年までの動向、予測、競合分析

顧みられない熱帯病診断（NTDs）の動向と予測

世界の顧みられない熱帯病診断市場は、2024年から2030年にかけてCAGR 4.9％で成長すると予測されます。この市場の主な促進要因は、見過ごされている熱帯病が増加していること、迅速診断検査に対する需要が高まっていること、そしてNTDsに対する認識が高まっていることです。世界の顧みられない熱帯病診断市場の将来は、病院・クリニック、在宅ヘルスケア、臨床検査市場において有望です。

顧みられない熱帯病診断市場の洞察

Lucintelは、先進国におけるデングウイルス検出のためのポイントオブケア検査の採用増加により、デング熱が予測期間中最大のセグメントであり続けると予測しています。

この市場において、臨床検査室は、世界中の検査室数の増加と臨床検査室における高度な機器の利用可能性の高まりにより、最大セグメントであり続けると思われます。

北米は、熟練したヘルスケア専門家の存在と、同地域における在宅医療でのポイントオブケア検査サービスの採用増加により、予測期間中も最大セグメントであり続けると思われます。

よくある質問

Q1.市場の成長予測は？

A1.世界の顧みられない熱帯病診断市場は、2024年から2030年にかけてCAGR 4.9％で成長すると予測されています。

Q2.市場の成長に影響を与える主な促進要因は？

A2.この市場の主な促進要因は、見過ごされている熱帯病の数の増加、迅速診断検査に対する需要の高まり、そして顧みられない熱帯病に対する認識の高まりです。

Q3.市場の主要セグメントは？

A3.顧みられない熱帯病診断市場の将来は、病院・クリニック、在宅ヘルスケア、臨床検査市場において有望です。

Q4.市場の主要企業は？

A4.顧みられない熱帯病診断の主要企業は以下の通りです。

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Q5.今後、最大となる市場セグメントは？

A5.Lucintelは、先進国におけるデングウイルス検出のためのポイントオブケア検査の採用増加により、デング熱が予測期間中最大のセグメントであり続けると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は？

A6.北米は、熟練したヘルスケア専門家が存在し、在宅医療におけるポイントオブケア検査サービスの採用が増加しているため、予測期間中も最大セグメントであり続ける。

Q7.レポートのカスタマイズは可能？

A7.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の顧みられない熱帯病診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の顧みられない熱帯病診断市場動向（2018～2023年）と予測（2024～2030年）
• 世界の顧みられない熱帯病診断市場：疾患の種類別
  • デング熱
  • チクングニア熱
  • 狂犬病
  • リンパ系フィラリア症
  • ブルーリ潰瘍
  • 食中毒吸虫症
  • エキノコックス症
  • ハンセン病
  • その他
• 世界の顧みられない熱帯病診断市場：方法別
  • 従来の方法
  • 分子法
• 世界の顧みられない熱帯病診断市場：サービスタイプ別
  • 一元化されたサービス
  • ポイントオブケア検査
• 世界の顧みられない熱帯病診断市場：最終用途別
  • 病院と診療所
  • 在宅ヘルスケア
  • 臨床検査室
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の顧みられない熱帯病診断市場
• 北米の顧みられない熱帯病診断市場
• 欧州の顧みられない熱帯病診断市場
• アジア太平洋の顧みられない熱帯病診断市場
• その他地域の顧みられない熱帯病診断市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 疾患の種類別
  • 方法別
  • サービスタイプ別
  • 最終用途別
  • 地域別
• 世界の顧みられない熱帯病診断市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の顧みられない熱帯病診断市場の能力拡大
  • 世界の顧みられない熱帯病診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Neglected Tropical Disease Diagnosis Trends and Forecast

The future of the global neglected tropical disease diagnosis market looks promising with opportunities in the hospital and clinic, home healthcare, and clinical laboratory markets. The global neglected tropical disease diagnosis market is expected to grow with a CAGR of 4.9% from 2024 to 2030. The major drivers for this market are escalating number of overlooked tropical diseases, rising demand for rapid diagnostic tests, and mounting recognition of NTDs.

A more than 150-page report is developed to help in your business decisions.

Neglected Tropical Disease Diagnosis by Segment

The study includes a forecast for the global neglected tropical disease diagnosis by disease type, method, service type, end use, and region.

Neglected Tropical Disease Diagnosis Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Dengue
• Chikungunya
• Rabies
• Lymphatic Filariasis
• Buruli Ulcer
• Foodborne Trematodiases
• Echinococcosis
• Leprosy
• Others

Neglected Tropical Disease Diagnosis Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Conventional Method
• Molecular Method

Neglected Tropical Disease Diagnosis Market by Service Type [Shipment Analysis by Value from 2018 to 2030]:

• Centralized Service
• Point-of-Care Testing

Neglected Tropical Disease Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospital and Clinic
• Home Healthcare
• Clinical Laboratories
• Others

Neglected Tropical Disease Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Neglected Tropical Disease Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neglected tropical disease diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neglected tropical disease diagnosis companies profiled in this report include-

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Neglected Tropical Disease Diagnosis Market Insights

Lucintel forecasts that dengue will remain the largest segment over the forecast period due to increasing adoption of point-of-care testing for dengue virus detection in developed nations.

Within this market, clinical laboratory will remain the largest segment due to increased number of laboratories across world and rising availability of advanced equipment in clinical laboratories.

North America will remain the largest segment over the forecast period due to existence of skilled healthcare professionals and growing adoption of point-of-care testing services at home healthcare in the region.

Features of the Global Neglected Tropical Disease Diagnosis Market

Market Size Estimates: Neglected tropical disease diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neglected tropical disease diagnosis market size by various segments, such as by disease type, method, service type, end use, and region in terms of value ($B).

Regional Analysis: Neglected tropical disease diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease types, methods, service types, end uses, and regions for the neglected tropical disease diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neglected tropical disease diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for neglected tropical disease diagnosis market?

Answer: The global neglected tropical disease diagnosis market is expected to grow with a CAGR of 4.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the neglected tropical disease diagnosis market?

Answer: The major drivers for this market are escalating number of overlooked tropical diseases, rising demand for rapid diagnostic tests and mounting recognition of ntds.

Q3. What are the major segments for neglected tropical disease diagnosis market?

Answer: The future of the neglected tropical disease diagnosis market looks promising with opportunities in the hospital and clinic, home healthcare, and clinical laboratory markets.

Q4. Who are the key neglected tropical disease diagnosis market companies?

Answer: Some of the key neglected tropical disease diagnosis companies are as follows.

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Q5. Which neglected tropical disease diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that dengue will remain the largest segment over the forecast period due to increasing adoption of point-of-care testing for dengue virus detection in developed nations.

Q6. In neglected tropical disease diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to existence of skilled healthcare professionals and growing adoption of point-of-care testing services at home healthcare in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neglected tropical disease diagnosis market by disease type (dengue, chikungunya, rabies, lymphatic filariasis, buruli ulcer, foodborne trematodiases, echinococcosis, leprosy, and others), method (conventional method and molecular method), service type (centralized service and point-of-care testing), end use (hospital and clinic, home healthcare, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neglected Tropical Disease Diagnosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Neglected Tropical Disease Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Neglected Tropical Disease Diagnosis Market by Disease Type
  • 3.3.1: Dengue
  • 3.3.2: Chikungunya
  • 3.3.3: Rabies
  • 3.3.4: Lymphatic Filariasis
  • 3.3.5: Buruli Ulcer
  • 3.3.6: Foodborne Trematodiases
  • 3.3.7: Echinococcosis
  • 3.3.8: Leprosy
  • 3.3.9: Others
• 3.4: Global Neglected Tropical Disease Diagnosis Market by Method
  • 3.4.1: Conventional Method
  • 3.4.2: Molecular Method
• 3.5: Global Neglected Tropical Disease Diagnosis Market by Service Type
  • 3.5.1: Centralized Service
  • 3.5.2: Point-of-Care Testing
• 3.6: Global Neglected Tropical Disease Diagnosis Market by End Use
  • 3.6.1: Hospital and Clinic
  • 3.6.2: Home Healthcare
  • 3.6.3: Clinical Laboratories
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Neglected Tropical Disease Diagnosis Market by Region
• 4.2: North American Neglected Tropical Disease Diagnosis Market
  • 4.2.2: North American Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others
• 4.3: European Neglected Tropical Disease Diagnosis Market
  • 4.3.1: European Neglected Tropical Disease Diagnosis Market by Disease Type: Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and Others
  • 4.3.2: European Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others
• 4.4: APAC Neglected Tropical Disease Diagnosis Market
  • 4.4.1: APAC Neglected Tropical Disease Diagnosis Market by Disease Type: Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and Others
  • 4.4.2: APAC Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others
• 4.5: ROW Neglected Tropical Disease Diagnosis Market
  • 4.5.1: ROW Neglected Tropical Disease Diagnosis Market by Disease Type: Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and Others
  • 4.5.2: ROW Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Disease Type
  • 6.1.2: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Method
  • 6.1.3: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Service Type
  • 6.1.4: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by End Use
  • 6.1.5: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Region
• 6.2: Emerging Trends in the Global Neglected Tropical Disease Diagnosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Neglected Tropical Disease Diagnosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neglected Tropical Disease Diagnosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Thermo Fisher Scientific
• 7.3: InBios International
• 7.4: Omega Diagnostics
• 7.5: Oscar Medicare
• 7.6: EUROIMMUN
• 7.7: Novartis
• 7.8: Grifols
• 7.9: ZeptoMetrix
• 7.10: DiaSys Diagnostic Systems